Search results for " Medicina Interna"

showing 10 items of 1302 documents

Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Ital…

2001

Several reports have indicated that fecal elastase-1 (EL-1) determination is a new, sensitive, and specific noninvasive pancreatic function test; however, very few patients with malabsorption due to small intestine diseases have been included in the previous studies. The aim of the study was to compare the diagnostic accuracy of fecal EL-1 and fecal chymotrypsin (FCT) in distinguishing between pancreatic maldigestion and intestinal malabsorption. Three groups of subjects were studied: group A included 49 patients with known cystic fibrosis (25 males, median age 5 years); group B included 43 subjects with various small intestine diseases (17 males, median age 6 years); and group C included 4…

AdultMaleSettore MED/09 - Medicina InternaAdolescentCystic FibrosisIntestinal giardiasiFecesSensitivityMalabsorption Syndromesspecificity; pancreatic insufficiency; sensitivity; malabsorption syndrome; intestinal giardiasis; cystic fibrosis; steatorrhea; fecal elastase-1: fecal chymotrypsin; celiac diseaseMalabsorption syndromeCeliac diseaseHumansintestinal giardiasisChildPancreatic ElastaseGastroenterologyInfant NewbornInfantPancreatic DiseasesReproducibility of ResultsClinical Enzyme TestsSteatorrheaIntestinal DiseasesCystic fibrosiChild PreschoolSpecificityFecal elastase-1: fecal chymotrypsinDigestionFemalePancreatic insufficiencyDigestive diseases and sciences
researchProduct

Polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein are associated with chronic spontaneous urticaria and urinary leukotriene E4

2011

The mechanisms of chronic spontaneous urticaria (CSU) continue to be unknown. Our working hypothesis is that polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein may be involved in the pathways leading to CSU. We examined five candidate polymorphisms of cyclo-oxygenases 1 and 2 and of 5-lipo-oxygenase-activating protein in 109 controls and in 94 CSU patients from Northern Italy. We also examined the levels of urinary leukotriene E4 (LTE4) before and after challenge with ASA. A multiple regression model was found to show that COX-2 5'UTR T/G, COX-2 Exon 10 T/C, and FLAP -336 G/A polymorphisms were significantly associated with CSU, with the minor allele more represented …

AdultMaleSettore MED/09 - Medicina InternaAdolescentGenotypeUrticariaUrinary system5-Lipoxygenase-Activating ProteinsSingle-nucleotide polymorphismDermatologyYoung Adultchemistry.chemical_compoundExonchronic spontaneous urticaria hypersensivity to aspirin cyclo-oxygenases 5-lipo-oxygenase-activating protein urinary leukotriene E4GenotypeHumansMedicineAllele5-lipoxygenase-activating proteinAgedLeukotriene E4Settore MED/04 - Patologia GeneraleLeukotriene E4Polymorphism Geneticbiologybusiness.industryMiddle AgedMinor allele frequencychemistryProstaglandin-Endoperoxide SynthasesChronic DiseaseImmunologybiology.proteinFemalebusiness
researchProduct

A comparison between two different in vitro basophil activation tests for gluten- and cow's milk protein sensitivity in irritable bowel syndrome (IBS…

2013

Abstract Background: The diagnosis of food hypersensitivity (FH) in adult patients with gastrointestinal symptoms, beyond the immediate IgE-mediated clinical manifestations, is very often difficult. The aims of our study were to: 1) evaluate the frequency of FH in patients with irritable bowel syndrome (IBS)-like clinical presentation; and 2) compare the diagnostic accuracy of two different methods of in vitro basophil activation tests. Methods: Three hundred and five patients (235 females, age range 18–66 years) were included and underwent a diagnostic elimination diet and successive double-blind placebo-controlled (DBPC) challenges. Two different methods of in vitro basophil activation te…

AdultMaleSettore MED/09 - Medicina InternaAdolescentGlutensClinical Biochemistrygluten-sensitivityIrritable Bowel SyndromeYoung AdultElimination dietMedicineHumansYoung adultIrritable bowel syndromeTriticumWhole bloodAgedchemistry.chemical_classificationCD63business.industryBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseMilk ProteinsGlutenIn vitroBasophilsBasophil activationCeliac Diseasebasophil activation test; gluten-sensitivity; irritable bowel syndromechemistrybasophil activation testImmunologyFemaleMilk Hypersensitivitybusiness
researchProduct

[Validity of the use of penbutolol in essential arterial hypertension].

1990

Thirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were treated with a beta-blocker (Penbutolol) alone and once a day to assess its antihypertensive effectiveness and its affect on heart frequency, lipid metabolism and kidney function. The drug proved highly effective in reducing P.A.S. and P.A.D. values and no negative influence was documented on lipid metabolism, kidney function or heart frequency.

AdultMaleSettore MED/09 - Medicina InternaAdult Aged Blood Pressure/drug effects Diastole Drug Evaluation Female Humans Hypertension/drug therapy* Male Middle Aged Penbutolol/therapeutic use* Propanolamines/therapeutic use* Systole SubstancesSystoleBlood PressureMiddle AgedSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolarePropanolaminesDiastoleHypertensionDrug EvaluationHumansFemalePenbutololAgedMinerva medica
researchProduct

Obesity, hypertension and atherosclerosis

1993

Hypertension and obesity are associated with an increased risk of clinical cardiovascular complications due to atherosclerosis. Moreover has been reported that hypertension may predispose to atheroma development. In the present review some common aspects to hypertension and atherosclerosis including smooth muscle cell proliferation, endothelial damage and intervention of growth factors have been analyzed. Additional data have to be provided to explain if the connections between hypertension and atherosclerosis could be considered two effects with one unknown cause. In addition some aspects related to obesity and atherosclerosis have been dissected. In particular we have reported our results…

AdultMaleSettore MED/09 - Medicina InternaArteriosclerosisMyocardial InfarctionLipidsSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareBlood Coagulation FactorsObesity hypertension atherosclerosisRisk FactorsHypertensionPrevalenceHumansFemaleObesity
researchProduct

[Effects of ACE inhibition with enalapril on the renal function of patients with essential arterial hypertension].

1987

AdultMaleSettore MED/09 - Medicina InternaBlood PressureMiddle AgedKidneyACE inhibition enalapril renal functionessential arterial hypertensionSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareEnalaprilHeart RateHypertensionHumansFemaleAgedMinerva cardioangiologica
researchProduct

Different prevalence of some indices of cardiac and vascular impairment in normal weight and obese patients with essential arterial hypertension

1989

Certain physiopathological features that differentiate essential arterial hypertension in normal weight and obese patients are recalled. The results of a retrospective study carried out in 293 hypertensive patients admitted to the Clinic in recent years are reported with a view to evaluating the prevalence of certain parameters (ischaemic cardiopathy, left ventricular hypertrophy, renal, vasculo-cerebral and retinal impairment) in patients subdivided into two groups: normal weight and obese. The study showed in the first group a higher prevalence of signs of ischaemic cardiopathy; in the second a higher prevalence of left ventricular hypertrophy. This difference is accentuated in the subgro…

AdultMaleSettore MED/09 - Medicina InternaBody WeightCardiomegalyCoronary DiseaseMiddle AgedSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareHypertensionAdult Body Weight* Cardiomegaly/etiology* Coronary Disease/etiology* Female Humans Hypertension/complications* Male Middle Aged Obesity/complications* Retrospective StudiesHumansFemaleObesityRetrospective Studies
researchProduct

Agenesis of the renal segment of inferior vena cava associated with venous stasis.

2010

Congenital anomalies of the inferior vena cava is an extremely rare vascular anomaly with controversial pathogenesis. Anomalies of the inferior vena cava (IVC) are present in 0.3% to 0.5% of otherwise healthy individual and in 0.6% to 2% of patients with other cardiovascular defects. The phenomenon of absence of the IVC has been described in a variety of ways such as absence, agenesis, anomalous, and interruption of a particular segment ([infra] hepatic, pre-renal, renal, or infrarenal) of the IVC. We describe a 42-year-old man with chronic venous insufficiency, without DVT, caused by congenital absence of renal segment of the IVC

AdultMaleSettore MED/09 - Medicina InternaCardiovascular AgentsVena Cava InferiorPhlebographySettore MED/11 - Malattie Dell'Apparato CardiovascolareCombined Modality TherapyExercise TherapyVenous InsufficiencyChronic DiseaseDiosminHumansAGENESIS OF THE RENAL SEGMENT OF INFERIOR VENA CAVA ASSOCIATED WITH VENOUS STASIS.Ultrasonography Doppler ColorTomography X-Ray ComputedStockings CompressionInternational angiology : a journal of the International Union of Angiology
researchProduct

Obesity and cardiovascular diseases.

1994

Obesity and overweight have great clinical and social significance and are associated with a number of medical and surgical complications. We attempt here to summarize current knowledge on the subject and describe the research we are presently carrying out in this field. After a brief introduction, definition, and discussion of etiopathogenesis, the indexes of ponderal excess and epidemiology are illustrated. The cardiovascular adjustments and the relationships between obesity and hypertension, ischemic heart disease and congestive heart failure are then treated. One aim of our investigation was to study the modifications of an entire set of biological and clinical parameters which could co…

AdultMaleSettore MED/09 - Medicina InternaCardiovascular DiseasesRisk FactorsObesity cardiovascular diseasesBody WeightHumansFemaleObesityMiddle AgedSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct

Relationship Between Human Leucocyte Antigen Class I and Class II and Chronic Idiopathic Urticaria Associated With Aspirin and/or NSAIDs Hypersensiti…

2006

Background. HLA genes play a role in the predisposition of several diseases. The aim was to analyze the prevalence of HLA class I phenotypes and HLA-DRB1*genotype in patients with CIU associated with ASA and NSAIDs hypersensitivity (AICU).Methods. 69 patients with AICU, and 200 healthy subjects.Results. Subjects with HLA-B44 and HLA-Cw5 antigens were more represented in patients with AICU than in control group. Subjects with HLA-A11, HLA-B13, HLACw4, and HLA-Cw7 antigen were more represented in control group than in patients with AICU. Multiple logistic regression demonstrated an association of HLA-Cw4 and HLA-Cw7 with a lower risk of AICU, whereas carriers of HLA-B44 phenotype had a higher…

AdultMaleSettore MED/09 - Medicina InternaChronic Idiopathic UrticariaGenotypeUrticariahuman leucocyte antigen class IImmunologyGenes MHC Class IIAnti-Inflammatory AgentsHuman leukocyte antigenLower riskDrug HypersensitivityResearch CommunicationAntigenGene FrequencyRisk FactorsGenotypelcsh:PathologyMedicineHumansAlleleAllele frequencyAllelesAspirinAspirinbusiness.industryAnti-Inflammatory Agents Non-SteroidalHistocompatibility Antigens Class ICase-control studyCell BiologyHLA-DR AntigensMiddle AgedNSAIDhuman leucocyte antigen class I; human leucocyte antigen class II; chronic idiopathic urticaria; aspirin; NSAIDs; hypersensitivityhuman leucocyte antigen class IIMHC Class IIPhenotypeGenesCase-Control StudiesImmunologyFemalehypersensitivityNon-Steroidalbusinesslcsh:RB1-214medicine.drugHLA-DRB1 ChainsMediators of Inflammation
researchProduct